Skip to Content

Global Pharmatech Inc GBLP

Rating as of

Morningstar’s Analysis

Valuation
Currency in
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Global Pharmatech Inc through its subsdiaries, discovers, develops, manufactures and markets proprietary drugs developed based on Traditional Chinese Medicine (TCM) while utilizing modern facilities and advanced R&D technologies. Geographically, the major business activities are carried out through People's Republic of China with sales distribution in China, Hong Kong, Singapore, Malaysia, Indonesia and USA.

Contact
89 Ravine Edge Drive
Richmond Hil, L4E 4J6
T +1 905 787-8225
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Jun 30, 2008
Fiscal Year End Dec 31, 2008
Stock Type Distressed
Employees 217